Amarin Corporation plc (NASDAQ:AMRN)
Cowen 42nd Annual Health Care Conference
March 07, 2022 9:10 AM ET
Company Participants
Karim Mikhail - President & Chief Executive Officer
Conference Call Participants
Ken Cacciatore - Cowen
Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
Ken Cacciatore
00:02 Great, thanks so much David for putting us in and Karim, thanks for joining us. It's really great to have you, a real exciting time and I know there's been a lot of exciting times, maybe too many exciting times for Amarin, but we're truly on the cusp of one now, and there's never been any doubt about really the quality of the product and the good that this products can do for patients. It's clearly been more business issues and legal issues that have kind of constrain the valuation and to a certain extent may be constrained in getting this product to patients, which is a little bit sad. So, we want to talk about all of it.
00:45 And I believe you're joining us from Europe and that's exactly where we wanted to start. So, you're physically -- and in the location, we'd want to kind of begin the conversation. So, for us here at Cowan, obviously, Europe is a key component to when we look at the value of Amarin, one of the, the biggest wildcards obviously, a lot of controversy. One of the other issues that we have a hard time kind of getting our arms around this, obviously, the value that you're going to be able to achieve for the product over there. We have no doubts that you'll be able to get a price but
- Read more current AMRN analysis and news
- View all earnings call transcripts